Systemic Amyloidosis in Behçet's Disease

  1. TALMA ROSENTHAL, M.D.;
  2. HARRY BANK, M.D.;
  3. MORDECHAI ALADJEM, M.D.;
  4. RAFFAELE DAVID, M.D.; and
  5. JOSEPH GAFNI, M.D.
  1. Tel-Hashomer and Tel-Aviv
    Israel

    Abstract

    Clinical features in two patients with Behçet's disease were dominated by "minor" manifestations of the disease—arthritis and central nervous system involvement in one, chronic stasis ulcers complicating thrombosis of the inferior vena cava in the other. In a third patient, the dominant clinical features were coincidental obstructive airway disease and cor pulmonale. Two patients developed a nephrotic syndrome; the third had intermittent trace proteinuria. Amyloidosis was proved by histologic examination in all three. The two patients examined post-mortem had no focus of chronic suppuration. There is a possibility that systemic amyloidosis is an intrinsic feature of Behçet's disease.

    Article and Author Information

    • ▸From the Heller Institute of Medical Research and the Departments of Internal Medicine, Pediatrics, and Pathology, Sheba Medical Center, Tel-Hashomer; and Tel-Aviv University Medical School, Tel-Aviv; Israel.

    • ▸Requests for reprints should be addressed to Joseph Gafni, M.D., Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Israel.

    « Previous | Next Article »Table of Contents